Carregant...
Minimum biopsy set for HER2 evaluation in gastric and gastro-esophageal junction cancer
Background and study aims: The HER2 status of small endoscopic biopsies is important for predicting the eligibility of patients with metastatic HER2-positive gastric cancer or gastro-esophageal junction (GEJ) cancer for anti-HER2 therapy approved by the U.S. Food and Drug Administration. The aim of...
Guardat en:
| Publicat a: | Endosc Int Open |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
© Georg Thieme Verlag KG
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4477016/ https://ncbi.nlm.nih.gov/pubmed/26135662 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0034-1391359 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|